(Q82137147)
Statements
IGF-II serum levels increase discrimination between benign prostatic hyperplasia and prostate cancer and improve the predictive value of PSA in clinical staging (English)
Lutz Trojan
Christel Weiss
Doris Mayer
Rainer Grobholz
Peter Alken
Maurice Stephan Michel
286-92; discussion 292